These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 11770807)

  • 1. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K; Podracká L; Heidland A; Schinzel R
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of advanced glycation end products in children with renal disease.
    Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
    Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
    Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
    Fragedaki E; Nebel M; Schupp N; Sebekova K; Völkel W; Klassen A; Pischetsrieder M; Frischmann M; Niwa T; Vienken J; Heidland A; Stopper H
    Nephrol Dial Transplant; 2005 Sep; 20(9):1936-43. PubMed ID: 15919695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
    Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protective effects to the function of kidney and long by clearing of cytokines in patients with open-heart surgery].
    Zhang GH; Hou FF; Wang WJ; Zhang X; Wu H; Liu ZQ; Tao HQ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3194-8. PubMed ID: 16405839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic inflammation in pediatric patients receiving hemodialysis.
    Goldstein SL; Currier H; Watters L; Hempe JM; Sheth RD; Silverstein D
    J Pediatr; 2003 Nov; 143(5):653-7. PubMed ID: 14615740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
    Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
    Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
    J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.